SAVELLA

Peak

milnacipran hydrochloride

NDAORALTABLET
Approved
Jan 2009
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1

Clinical Trials (1)

NCT01026077N/ATerminated

The Savella Pregnancy Registry

Started Nov 2009
350 enrolled
Fibromyalgia

Loss of Exclusivity

LOE Date
Sep 19, 2029
43 months away
Patent Expiry
Sep 19, 2029

Patent Records (1)

Patent #ExpiryTypeUse Code
7994220
Sep 19, 2029
U-819